Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Prostate. 2019 Jan 20;79(6):628–639. doi: 10.1002/pros.23767

FIGURE 3.

FIGURE 3

Alternol attenuates Krebs cycle enzymatic activities. A-D, Prostate cancer cells and BPH1 cells were treated with the solvent DMSO or Alternol (10 μM) for 4 h and whole cellular proteins were extracted for the enzymatic assays as indicated with the pre-assembled assay kits from BioVision. The asterisks indicate significant differences (Student’s t-test, P < 0.05) between Alternol treatment and DMSO control. The # signs indicate significant differences (Student’s t-test, P < 0.05) between malignant cells and BPH1 cells in DMSO control group